Please login to the form below

OPEN Health at the World Orphan Drug Conference USA

Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !

Our Director of Rare Disease, Gavin Jones, is looking forward to his conversation with Emily Reuben (m.Crossley) and Betsy Bogard at #WODCUSA2020! He values the opportunity to speak to people at the front line of efforts to bring gene therapies to patients living with a rare disease and is sure the audience will do too. They will be sharing their thoughts based on the core themes of education and value demonstration that OPEN Health recently shared in a white paper.

This demonstrating our commitment to leading the conversation on how effective healthcare communications, and tools that enable them, can lead to faster and sustained patient access to gene and other advanced therapies. We brought together experience and capabilities from across our practices to develop broad thinking on ‘Succeeding with Star Wars Medicine – translating the science and value of gene therapy to key stakeholders’. The thinking is based on three key foundations:

  • Leading a patient first approach
  • Communicating the science
  • Demonstrating Value
Pink divider

Please find a short video of our Director of Rare Disease, Gavin Jones, describing why we have invested in this white paper and what you can expect from our recommendations.

Pink divider

To arrange a virtual presentation to discuss the findings and to receive a copy of the white paper please contact: gavinjones@openhealthgroup.com

12th August 2020

Share

Company Details

OPEN Health

+44 1628 481112

Contact Website

Address:
The Weighbridge
Brewery Courtyard
High Street
Marlow
Buckinghamshire
SL7 2FF
United Kingdom

Latest content on this profile

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member
OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.
OPEN Health
Steve Chick joins OPEN Health as Chief Growth Officer for Evidence & Access
OPEN Health is pleased to announce the appointment of Stephen J. Chick as Chief Growth Officer for OPEN Health Evidence & Access.
OPEN Health
OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital
OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical communications platform from NaviMed Capital (“NaviMed”).
OPEN Health
How digital health is changing the relationship between patients and health providers | OPEN Health
The pandemic has forced pharmaceutical industry to look at digital in a new way - and it’s driving better health outcomes
OPEN Health
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
David Thompson joins OPEN Health as Chief Executive Officer for Evidence & Access
OPEN Health
OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver
OPEN Health Appoints Chief Medical Officer Annemarie Clegg, MD, and Chief Commercial Officer Jennifer Chilver
OPEN Health